Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Protein Analysis Reagents
  4. Lysates
  5. Overexpression Lysates
  6. NBL107979

Novus Biologicals™ BID Overexpression Lysate
SDP

Catalog No. NBL107979 Shop All R&D Systems Products
Change view
Click to view available options
0.1 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No.
NBL107979 0.1 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NBL107979 Supplier Novus Biologicals™ Supplier No. NBL107979
Only null left
Add to Cart
Add to Cart

Description

The BID Overexpression Lysate is derived from human. It has been validated for the following applications: Western Blot.

Specifications

Cell Line The lysate was created in HEK293T cells, using plasmid ID RC27261 and based on accession number NM_1196. The protein contains a C-terminal DDK tag.
For Use With (Application) Western Blot
Quantity 0.1 mg
Storage Buffer RIPA buffer
Purity Protein
Test Specificity Homo sapiens BH3 interacting domain death agonist (BID), transcript variant 2, mRNA.
Content And Storage Store at -80 C. Avoid freeze-thaw cycles.
Research Category Apoptosis, Cancer, Tumor Suppressors
Target BID
Synonym apoptic death agonist, BH3 interacting domain death agonist, BH3-interacting domain death agonist, BID isoform ES(1 b), BID isoform L(2), BID isoform Si6, desmocollin type 4, FP497, Human BID coding sequence, MGC15319, MGC42355, p22 BID, tbid
Gene Symbol BID
Protein State Native
Show More Show Less

For Research Use Only

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.